We develop algorithms that improve the digital pathology workflow and certified clinical diagnostic algorithms that augment pathologists.
We support CROs and biopharma with AI-powered solutions to identify novel pathology-based biomarkers that can accelerate drug development.
We enable AI and data providers to ensure the use of only high-quality, artifact-free images.
We provide AiosynQC, an AI-powered solution for automated quality control of digital histology slides in the pathology workflow.
We provide Aiosyn Mitosis, an AI-powered solution to aid clinical and research labs identify mitotic figures in H&E sections.
Aiosyn’s NephroPath platform harnesses AI-powered computational pathology algorithms that provide precise quantification of kidney lesion scores.
We offer detailed evaluations of slide quality through AiosynQC Pulse, helping labs identify areas for improvement, optimize workflows, and enhance team performance through targeted training and education.
We provide AI-powered kidney histopathology evaluations and biomarker scoring as a service through our NephroPath platform, empowering researchers and pathologists with precise, quantitative insights for kidney disease studies.
Copyright Aiosyn 2025. All rights reserved. Privacy policy | Cookie policy